| Age (years): mean ± standard deviation |
44.8 ± 19.1 |
45.6 ± 18.5 |
0.80 |
| Male: n patients (%) |
35 (65) |
85 (67) |
0.81 |
| Diabetes: n patients (%) |
3 (6) |
8 (6) |
0.84 |
| % TBSA burn: median, IQR |
7 (3–14) |
4.5 (1.5–7) |
<0.01 |
| % TBSA debrided at first operation: median, IQR |
6.25 (2–12) |
3 (1–7) |
<0.01 |
| High risk location of burn (face/hand/foot/perineum): n patients (%) |
33 (61) |
70 (56) |
0.49 |
| Days of surgery post injury: median, IQR |
1.5 (1–4) |
3 (1–6) |
<0.01 |
| Preoperative growth: n patients (%) |
13 (24) |
40 (32) |
0.30 |
| Preoperative antibiotic use: n patients (%) |
9 (17) |
29 (23) |
0.34 |
| Excisional debridement only: n patients (%) |
8 (15) |
8 (6) |
0.07 |
| Scrub debridement and Biobrane™: n patients (%) |
21 (39) |
21 (17) |
<0.01 |
| Excisional debridement and Biobrane™: n patients (%) |
8 (15) |
11 (9) |
0.22 |
| Excisional debridement and skin graft: n patients (%) |
17 (31) |
86 (68) |
<0.01 |